Mometasone Furoate Monohydrate
141646-00-6C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl.OAQCCVUHZMIMSIB-HRVPQZBTSA-NSee other relationships...
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Danger
H331 (66.7%): Toxic if inhaled [Danger Acute toxicity, inhalation]
P203, P260, P261, P271, P273, P280, P304+P340, P316, P318, P319, P321, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 18 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
MOMETASONE FUROATE MONOHYDRATE
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Substances that reduce or suppress INFLAMMATION.
Drugs used to treat or prevent skin disorders or for the routine care of skin.
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)
141646-00-6